Profile
Simon John Harford worked as Non-Executive Director at GlaxoSmithKline Pharmaceuticals Ltd. He was Non-Executive Director at C4X Discovery Holdings Ltd. from 2021 to 2024.
He served as Group Vice President & Controller at Avon Products, Inc. He held the position of Vice President & Controller at Eli Lilly & Co. He was Chief Financial Officer & Senior Vice President at PAREXEL International Corp.
from 2017 to 2018.
He worked as Senior VP-Finance & Global Pharmaceuticals at GSK Plc from 2015 to 2017.
He was Chief Financial Officer & Treasurer at Albireo Pharma, Inc. from 2018 to 2023.
He held the role of Chief Financial Officer at Amicus Therapeutics, Inc. from 2023 to 2026.
Mr. Harford earned an MBA degree from the University of Virginia Darden School of Business.
Former positions of Simon Harford
| Companies | Position | End |
|---|---|---|
| AMICUS THERAPEUTICS, INC. | Director of Finance/CFO | 27/04/2026 |
| C4X DISCOVERY HOLDINGS PLC | Director/Board Member | 22/07/2024 |
| PAREXEL INTERNATIONAL CORPORATION | Director of Finance/CFO | 20/08/2018 |
| GSK PLC | Corporate Officer/Principal | 01/04/2017 |
| ALBIREO PHARMA, INC. | Director of Finance/CFO | - |
Training of Simon Harford
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 9 |
|---|---|
Avon Products, Inc.
Avon Products, Inc. Household/Personal CareConsumer Non-Durables Manufactures and distributes beauty, skincare, fragrance & cosmetics products | Consumer Non-Durables |
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
PAREXEL International Corp.
PAREXEL International Corp. BiotechnologyHealth Technology Operates as a clinical research organization which provides insights-driven clinical and consulting solutions | Health Technology |
Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures novel medicines for rare diseases | Health Technology |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
GlaxoSmithKline Pharmaceuticals Ltd.
GlaxoSmithKline Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Engages in the business of manufacturing, distributing and trading in pharmaceuticals | Health Technology |
University of Virginia Darden School of Business
University of Virginia Darden School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
C4X Discovery Holdings Plc
C4X Discovery Holdings Plc Pharmaceuticals: MajorHealth Technology Operates as a drug discovery company | Health Technology |
Albireo Pharma, Inc.
Albireo Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets novel bile acid modulators for liver and gastrointestinal diseases and disorders | Health Technology |
- Stock Market
- Insiders
- Simon Harford
















